Valuation Gujarat Terce Laboratories Limited

Stocks

Market Closed - Bombay S.E. 06:27:01 2026-10-21 EDT			5-day change	1st Jan Change
34.69 ^INR	-1.03%		-14.32%	-20.25%

08-07	Gujarat Terce Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-29	Gujarat Terce Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	51.65	194	123.6	392.9	453.7	240.8
Change	-	275.72%	-36.29%	217.83%	15.47%	-46.93%
Enterprise Value (EV) ¹	86.15	245.7	176	430.7	450.2	211.6
Change	-	185.15%	-28.34%	144.64%	4.53%	-52.99%
P/E	-2.05x	22.2x	-7.4x	161x	-46.3x	10.6x
PBR	0.67x	2.27x	1.8x	5.53x	7x	2.47x
PEG	-	-0x	0x	-1x	0x	-0x
Capitalization / Revenue	0.21x	0.48x	0.26x	0.82x	0.9x	0.51x
EV / Revenue	0.34x	0.61x	0.38x	0.9x	0.9x	0.45x
EV / EBITDA	-2.92x	22x	-8.15x	34x	11.6x	5.65x
EV / EBIT	-2.76x	29.2x	-6.98x	47.9x	12.9x	6.36x
EV / FCF	-10.7x	-7.43x	84.1x	24.5x	8.13x	36.1x
FCF Yield	-9.39%	-13.5%	1.19%	4.08%	12.3%	2.77%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-3.4	1.176	-2.253	0.328	-1.32	2.92
Distribution rate	-	-	-	-	-	-
Net sales ¹	251.8	401.3	467.8	479.7	502	474.7
EBITDA ¹	-29.46	11.18	-21.59	12.67	38.83	37.48
EBIT ¹	-31.23	8.416	-25.24	8.99	34.98	33.25
Net income ¹	-25.2	8.723	-16.72	2.434	-9.787	22.02
Net Debt ¹	34.51	51.63	52.42	37.76	-3.49	-29.11
Reference price ²	6.96	26.15	16.66	52.95	61.14	30.90
Nbr of stocks (in thousands)	7,420	7,420	7,420	7,420	7,420	7,791
Announcement Date	8/11/21	8/1/22	8/1/23	8/24/24	7/28/25	7/28/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GUJARAT TERCE LABORATORIES LIMITED	-	-	-	-	2.88M
ELI LILLY AND COMPANY	36.99x	13.22x	28x	0.53%	1,144B
JOHNSON & JOHNSON	37.96x	6.39x	17.99x	2.06%	625B
ABBVIE INC.	36.9x	8.47x	17.49x	2.38%	511B
ROCHE HOLDING AG	21.13x	5.1x	12.68x	2.57%	377B
MERCK & CO., INC.	108.1x	6.04x	25.89x	2.3%	366B
NOVARTIS AG	21.5x	5.61x	13.79x	2.85%	291B
ASTRAZENECA PLC	22.06x	4.46x	12.76x	1.98%	262B
AMGEN INC.	27.87x	7.15x	12.8x	2.3%	237B
GILEAD SCIENCES, INC.	-45.73x	7.01x	27.13x	2.11%	194B
Average	29.64x	7.05x	18.73x	2.12%	400.79B
Weighted average by Cap.	35.48x	8.34x	20.49x	1.8%